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Abstract
Purpose. The purpose of this practice improvement project was to increase cardiovascular
disease (CVD) knowledge in women of color (WOC) in the primary care setting through
enhanced provider to patient education through implementation of a provider toolbox.
Background. CVD is the number one cause of death in women in the United States. However,
WOC have a higher incidence of CVD than White women. Additionally, WOC have been found
to have a decreased knowledge and awareness of CVD, demonstrated by numerous national
studies. Therefore, the primary investigator (PI) identified a need to increase CVD knowledge
and awareness in WOC in order to improve heart health outcomes in this patient population.
Methods. An evidenced-based toolbox on CVD prevention in WOC for provider use was
assembled by the PI. The toolbox was distributed to providers at Sea Mar Monroe clinic with an
accompanying voiceover PowerPoint with instructions for intended use. A follow up mixedmethods survey was sent to participants which aimed to evaluate the toolbox itself, its expected
impact on patient outcomes and identify implications for future practice. Results. All
participants (n=4) strongly agreed that the toolbox informed their knowledge on this clinical
practice issue, strongly agreed that it will help them optimize cardiovascular health in WOC, and
strongly agreed that it will facilitate evidenced-based practice. Half of the participants strongly
agreed, and half agreed, that they felt better equipped to address this clinical practice issue after
using the toolbox. Themes identified included time as a barrier for optimal CVD education for
both patients and providers, conceptualizing race as a specific risk factor and lack of
prioritization to take preventative action by WOC. Conclusion. WOC have a higher incidence of
CVD paired with a decreased knowledge and understanding. Primary care providers are in a
unique position to close this knowledge gap through patient education to reduce health
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disparities in this population. This toolbox resource facilitated provider to patient CVD education
in WOC.
Keywords: Cardiovascular disease, heart disease, women of color, patient education
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Introduction
Cardiovascular disease (CVD) is the number one killer of women in the United States,
claiming over 400,000 lives each year (American Heart Association, 2018). However, CVD
affects women of color (WOC) more often than White women. The prevalence of CVD is
approximately 48% in Black women, compared to 35% in Caucasian women (American Heart
Association, 2018). Additionally, African American women have the highest age-adjusted
mortality rate from CVD out of any female racial or ethnic group in the United States
(Villablanca et al., 2010), and Hispanic women are more likely to have risk factors associated
with CVD such as diabetes, overweight or obesity and physical inactivity (Giardina et al., 2013).
In addition to having a higher rate of CVD compared to White women, women of color
demonstrate decreased CVD knowledge and awareness (Reeder, 2017; Villablanca et al., 2016b).
Knowledge and awareness of CVD may include heart disease as the leading cause of death in
women, risk factors, preventative measures, signs and symptoms of a heart attack, and when and
how to take emergency action. The American Heart Association (AHA) found that only 36% of
Black women and 34% of Hispanic women identified heart disease as the leading cause of death
in women, compared to 65% of White women in their national survey (2018). Therefore, the
population with the highest risk for CVD possesses the least knowledge on what can be done to
prevent the occurrence of disease. Additionally, physicians are more likely to falsely rate women
at lower risk for CVD than men and underutilize preventative therapies (Bairey Merz, 2017;
Wenger, 2012). Thus, there is a need to close this gap in heart health knowledge between women
of color and White women in order to reduce further health disparity, hence the purpose of this
project.
Purpose & Aims
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The purpose of this project is to increase CVD knowledge and awareness in WOC in the
primary care setting through enhanced provider to patient education. The first aim was to
assemble a toolbox containing evidenced-based resources that would guide healthcare providers
in both patient education and the cardiovascular care of WOC. The second aim was to present
the toolbox to healthcare providers at the clinic and engage with them to utilize the toolbox as a
resource to facilitate preventative strategies with WOC. The third aim was to inform healthcare
providers on WOC’s decreased CVD knowledge and awareness so that they would take special
care to educate this patient population.
Background & Significance
Previous Efforts to Raising Awareness
CVD is a largely misunderstood disease by many. The false belief that CVD is
predominately a man’s disease still persists in society in present day (Galbraith, Mehta, Veledar,
Vaccarino, & Wenger, 2011). These misunderstandings encourage women to shy away from
protecting themselves from CVD because they do not personally think they are at risk.
Unfortunately, the literature reveals that even physicians are more likely to falsely rate women at
lower risk for CVD than men (Bairey Merz, 2017; Villablanca et al., 2010; Wenger, 2012). The
truth is that CVD impacts one in four women in the United States and is the leading cause of
death in both men and women (Reeder, 2017). Therefore, CVD is a substantial threat to women’s
health that many people, even doctors, underestimate. Awareness of CVD as the leading cause of
death in women has been positively associated with healthy lifestyle modifications and
preventive action in women (Christian et al., 2007). Efforts to increase knowledge and awareness
are necessary to encourage healthy behaviors in American women.
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Historically, efforts have been made by the American Heart Association to increase CVD
knowledge and awareness among American women over the last two decades. These campaigns
have been largely successful, nearly doubling awareness since 1997 (Villablanca et al., 2010).
While CVD knowledge and awareness have increased in White women over that time period,
gains have stagnated in WOC (AHA, 2018; Christian et al., 2007). This lack of knowledge and
awareness is therefore creating further health disparities.
Low Awareness in WOC
Present literature reveals that WOC have decreased knowledge and awareness of CVD
compared to White women (AHA, 2018). The majority remain unaware that CVD is a potential
threat to their wellbeing and, therefore, may not understand the importance of taking
preventative measures even after many awareness-raising campaigns. Knowledge and awareness
were found to be significantly lower in all groups of WOC, including Black, Hispanic and
American Indian women, compared to White women in a survey by Villablanca, Slee, Lianov, &
Tancredi (2016b). Data from another survey found that Black and Hispanic women were 66%
less likely than White women to correctly identify heart disease as the number one killer of
women as a whole, and that difference did not differ substantially between those two groups
(Mochari-Greenberger, Miller, & Mosca, 2012). Christian et al. (2007) concluded that awareness
was significantly lower in Black and Hispanic women than White women. The same survey
reported that Hispanic women were more likely to state that “there is nothing they can do to
prevent their risk of heart disease”. Asian women were also identified to have less CVD
knowledge and felt the least motivated to change their modifiable risk factors in a study
conducted by Galbraith et al. (2011). Overall, knowledge, awareness and how to take
preventative measures is cited as lowest in groups of WOC throughout the relevant literature.
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Highest Risk and Lowest Awareness
There is a high level of disparity among groups of WOC in regard to CVD prevalence,
morbidity and mortality. The literature demonstrates that knowledge and awareness is the lowest
in groups of women who have the highest risk of CVD, specifically WOC (Flink, Sciacca, Bier,
Rodriguez & Giardina, 2013). Out of all women in the United States, Black women have the
highest prevalence and death rate from CVD (AHA, 2018). African American women suffer
from the highest rates of hypertension and obesity, contributing to an increased risk of CVD
(Villablanca et al., 2016a). Reeder (2017) found that the majority of African American women
do not personally believe that they are personally at risk for CVD, according to the survey
conducted in the study. Additionally, Hispanic women suffer from diabetes, hypertension and
obesity at higher rates than White women, also putting them at a higher risk for developing CVD
(Giardina et al., 2013). Both a high Framingham Risk Score, which measures CVD risk, and a
diagnosis of metabolic syndrome were inversely related to CVD knowledge and awareness in a
study by Flink et al. (2013). Giardina et al. (2013) established that Hispanic women who were
overweight or obese also demonstrated decreased knowledge and awareness scores compared to
those who were normal weight. According to these findings, CVD prevention strategies are
needed in high-risk women who have the least knowledge and awareness.
Interventions for WOC
The majority of literature on the topic of WOC and CVD awareness is limited to nonexperimental surveys. Few studies implement an experimental intervention that examines how
educating WOC on CVD impacts overall health. However, researchers in a study by Villablanca
et al. (2016a) implemented a four-month long heart health program in a cohort of African
American women. The findings revealed a significant knowledge gain plus a significant
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reduction in clinical risk factors such as waist circumference, serum cholesterol levels and
inflammatory biomarkers. Participants also demonstrated a 60% decrease in metabolic syndrome
in the cohort of women studied. In another study, Villablanca et al. (2010) researchers
implemented a six-month long program that involved education, health behavior counseling and
risk reduction strategies in a group of women who were clinically at high risk for CVD. This
intervention showed a significant increase in knowledge and awareness. Additionally, there was
a general decrease in systolic blood pressure and LDL cholesterol with an increase in HDL
cholesterol among participants.
In conclusion, the present literature reveals that WOC, who have the highest risk for
CVD, have the least knowledge and awareness. Therefore, efforts to educate WOC on CVD
prevention and provide them with strategies to reduce their risk is an area of practice that can be
improved upon, and advanced practice providers and physicians are well-suited to help close this
knowledge gap in patients who are WOC.
Theoretical Framework
The theoretical framework used for this project was the Promoting Action on Research
Implementation in Health Services (PARIHS) Model. This framework focuses on the
implementation of research into practice through the interplay of three core elements: evidence,
context and facilitation (Rycroft-Malone, 2004). It served as a guide for the implementation
elements needed for successful adoption of the toolbox by the providers. Evidence refers to
knowledge from a variety of sources found to be credible. The element of evidence corresponds
to the assembly of a toolbox containing evidenced-based resources. Context refers to the
environment or setting in which people receive health services and the setting in which research
evidence is brought into practice. The element of context refers to the primary care clinic in
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which the toolbox will be implemented. The last element, facilitation, refers to the process of
enabling the implementation of evidence into practice. It also refers to leadership within the
organization and readiness for implementation of the project. This corresponds with the project
aim of bringing the research into practice through a convenient and user-friendly toolbox.
Methods
Design
This project was a practice improvement project with a summative survey evaluation.
The purpose of this project was to increase cardiovascular disease (CVD) knowledge and
awareness in women of color (WOC) in the primary care setting through enhanced provider to
patient education. The first aim was to assemble a toolbox containing evidenced-based resources
that will guide healthcare providers in both patient education and the cardiovascular care of
WOC. The second aim was to present the toolbox to healthcare providers at a primary care clinic
and engage them to utilize the toolbox as a resource to facilitate preventative strategies with
WOC. The third aim was to inform healthcare providers on WOC’s decreased CVD knowledge
and awareness so that they may better educate this patient population. The toolbox is a means of
disseminating information to providers in order to improve clinical practice and the health
outcomes of this patient population. The utility of the toolbox, its expected impact on patient
outcomes, provider knowledge after viewing the toolbox and presentation and implications for
future practice were evaluated through an online survey. This project was submitted to Seattle
University’s Institutional Review Board (IRB) and determined not to be human subjects research
and, therefore, exempt from further review.
Setting
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The setting of this practice improvement project was Sea Mar Community Health
Center’s Monroe location located in Monroe, Washington in Snohomish County. However, all
interaction with participants and all project processes were conducted virtually over Zoom or
email due to the COVID-19 pandemic and social distancing guidelines. The Monroe clinic serves
a diverse population of patients. Majority of the patients at Sea Mar Monroe are low income
earners and are underinsured or uninsured, and 80% are Latino and Spanish speaking.
Recruitment Plan & Participants
Inclusion criteria for participation was providers at the clinic (including physicians,
advanced registered nurse practitioners [ARNPs], physician assistants [PAs] or registered nurses
[RNs]) and relevant clinic personnel including health educators, care coordinators or
nutritionists. Exclusion criteria was medical assistants (MAs) and other support or office staff.
The site preceptor, an ARNP working at the clinic, identified the participants who met inclusion
criteria. One ARNP, four physicians, a health educator and a chronic care coordinator met
inclusion criteria. They were recruited via email by the primary investigator (PI). Participation
was defined as reviewing the toolbox, using it as a clinical resource in practice as appropriate
and participating in a follow up survey. Participation in this project was voluntary.
Intervention and Data Collection Procedures
The toolbox was assembled and formatted into a PDF document by the PI (See Appendix
A). The toolbox’s contents include general information on CVD, current practice guidelines,
local and national health indicators and statistics, patient education topics and resources, and
cultural considerations. The toolbox was distributed as an attachment to participants via email.
The body of the email contained a letter to participants that introduced the project and its
intention. A project timeline was also given. An accompanying voiceover PowerPoint
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presentation was also provided which gave further background on the project and instruction on
the toolbox’s intended use. The rationale for a voiceover PowerPoint was so that participants
would be able to view the presentation on their own time, facilitating convenience and
accommodating varying work schedules. The presentation encouraged participants to utilize the
toolbox resource in clinical practice. Six weeks later, a link to a Qualtrics survey was emailed to
participants. The aim of the survey questions was to evaluate the participant’s awareness of this
clinical practice issue, participant's assessment of the utility of the toolbox, its expected impact
on patient outcomes and identify implications for future practice. When participants clicked on
the link to the survey, there was an informed consent statement before the first question. Consent
was obtained by participants proceeding to the first question. Participants were encouraged to
complete the survey within two weeks with a reminder email sent one week in between.
However, due to low response rate, the PI sent an additional reminder via email four weeks after
the survey was initially distributed. The survey responses were kept anonymous. The PI analyzed
the survey results and formatted them into an executive summary that included both a written
explanation of the results and bar graphs depicting specific quantitative data. It was then
distributed to the participants via email (See Appendix B).
Measures and Instruments
The survey used in this project was a mixed methods survey because it included both
five-point Likert scale questions and free response questions (see Appendix C). The Likert scale
is a widely used instrument that assesses attitude by allowing participants to rate how much they
agree or disagree with a given statement. It assumes that the strength of an attitude is linear and
that attitudes can be measured in a quantifiable way (McLeod, 2019). There were four questions,
written as statements, and participants rated their attitudes on a five-point scale from strongly

15

agree, somewhat agree, neither agree nor disagree, somewhat disagree and strongly disagree.
Reliability was increased by using a five-point Likert scale for survey responses as opposed to
three- or four-point scales (McKelvie, 1978). There were five free response questions. Free
response questions are intended to elicit respondent comments, opinions, recommendations or
suggestions. Social desirability has been shown to reduce the validity of surveys, therefore,
keeping the survey responses anonymous was an effort to increase the validity of this evaluation
(McLeod, 2019).
Data Analysis
Data for analysis was obtained through the mixed methods Qualtrics survey described
above. The quantitative data was analyzed individually as a Likert-type item, rather than as a
composite scale which is done in traditional Likert-scales (Boone & Boone, 2012). The reason
for this is because the survey questions aimed to assess varying topics surrounding the toolbox,
so it would not have been logical to interpret them as a composite score. Data from the Likerttype is ordinal, and therefore, underwent descriptive statistics using Microsoft Excel.
Frequencies were counted and the median and mode were determined to assess central tendency
of responses. The qualitative data obtained from the free response questions underwent content
analysis for themes using Microsoft Word. Themes were grouped into broad, overarching
categories and then compared and contrasted. The frequencies were depicted in bar graph format.
Median and mode were also calculated and described. The qualitative data was summarized in
paragraph format.
Results
The participant survey had a 50% response rate (n=4). Overall, participants evaluated the
toolbox resource itself favorably. The quantitative data from the Likert-type items and fill in the
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blank item is described below with accompanying bar graphs indicating the frequency of
responses. The qualitative data from the free response questions is summarized below, organized
by each question.
Quantitative Data
Fill in the Blank Item. Participants were asked to estimate how many WOC patients
they see on a weekly basis for CVD (question 1). The mean was 15.3 patients according to
participants who answered this question (n=3). The median was 8 patients.
Likert-Type Items. All participants (n=4) strongly agreed that the toolbox informed their
knowledge on WOC and CVD (see Figure 1). Half of the participants strongly agreed that they
felt better equipped to address this clinical practice issue after viewing the toolbox and its
presentation, and the other half of participants somewhat agreed (see Figure 2). All participants
strongly agreed that the toolbox would enable them to optimize cardiovascular care of WOC at
risk for CVD (see Figure 3). All participants strongly agreed that the toolbox resource will help
them facilitate evidence-based practice in their practice setting (see Figure 4).
The median and mode were analyzed to determine central tendency of responses. The
scale for the responses ranged from numbers 1 through 5, with 1= strongly disagree and 5=
strongly agree. Based on this information, it can be determined that the central tendency of
responses was consistent with “strongly agree” for all questions except question three, which
ranged from “agree” to “strongly agree” (see Table 1).
Figure 1
Question 2
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Note. “This toolbox has informed my knowledge on this clinical practice issue.”
Figure 2
Question 3

Note. “I feel better equipped to address this clinical practice issue after viewing this toolbox and
presentation.”
Figure 3
Question 4
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Note. “The toolbox will enable me to optimize the cardiovascular care of women of color at risk
for CVD.”
Figure 4
Question 5

Note. “I anticipate that the toolbox resources will help me to facilitate evidence-based practice in
my practice setting.”
Table 1
Median and Mode of Likert-Type Item Responses
Variable

Median

Mode

Question 2

5

5

Question 3

4.5

4, 5

Question 4

5

5
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Question 5

5

5

Qualitative Data
Of the four participants who responded to the survey, only three participants completed
the free response questions (n=3). There was a total of four free response questions that
underwent content analysis for themes. The common themes identified were conceptualizing
race as a specific risk factor, time as a barrier for both providers and WOC, and money and lack
of prioritization as barriers for WOC. In addition to common themes, other findings are
described below due to the small sample size.
How has this toolbox impacted your approach to care of patients who are women of
color at risk for cardiovascular disease? Please explain. The common theme identified in the
analysis of the above question was specific risk factors for groups of WOC. One participant
stated, “I think it becomes second nature to always approach every patient in an algorithmic way,
and sometimes we forget that there are all these other variables such as race.” Another
participant reported that the toolbox has “made it easier for patients to understand how at risk
they are” according to their race or ethnicity.
How do you expect that provider use of this toolbox will impact patient outcomes?
Please explain. Answers to the above question varied by participant, therefore, no common
themes were identified. However, one participant addressed visualization as a way to help
patients better understand medical concepts. Another participant reported that the toolbox gave
them a better understanding of this clinical practice issue and how to approach it.
What barriers do you believe providers face in providing CVD education to
patients? Please explain. Time was the common theme across all participant responses. One
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participant reported fifteen-minute appointment times are a barrier to executing the best care,
including education, and another reported that there is not enough time allotted to cover
everything in detail in a single patient visit.
What barriers do you believe patients who are women of color face in taking action
to prevent their risk of CVD? Please explain. Both time and money were identified as a major
barrier to WOC seeking preventative care or following up on appointments. Participants
expressed that financial barriers decrease patient willingness to seek out preventative care.
Another theme was family prioritization. Participants described WOC patients as mothers,
spouses and full-time workers, making them more likely to put their own health “on the back
burner” and prioritize family needs above their own. Additionally, one participant identified lack
of understanding and a need for repeat education as a barrier.
Discussion
Overall, this practice improvement project was evaluated favorably by participants
through a summative survey evaluation. The survey questions aimed to evaluate changes in
provider knowledge of this clinical practice issue after using the toolbox and viewing its
presentation, the utility of the toolbox, its expected impact on patient outcomes and identify
implications for future practice.
Limitations
A primary limitation of this project was the limited number of participants. Sea Mar
Monroe is a small clinic and only eight participants were identified as eligible and, therefore,
invited to use the toolbox and participate in the follow up survey. Retrospectively, it may have
been useful to ask participants whether or not they actually used the toolbox. However, based on
the number or participants who responded to the survey, it is likely that only four of the eight
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total participants used the toolbox. For this reason, data for analysis was limited for both the
Likert-type items (n=4) and fill in the blank and free response questions (n=3). However,
participant’s responses were mostly consistent, giving the data some degree of meaningfulness.
Another limitation was participant engagement. Engaging with participants was
challenging due to the COVID-19 pandemic. The PI was limited to email as a means of
communicating with participants and it can be inferred that face-to-face communication would
have boosted participation and enthusiasm. However, this was not possible due to social
distancing guidelines at the time of implementation. Additionally, the site preceptor indicated
that it was challenging for participants to find extra time to review project materials due to
increased workload and demands of the clinic associated with the pandemic.
Implications for Future Practice
The information and resources in the toolbox served as a useful resource in both
increasing provider awareness of this health disparity and educating WOC patients on CVD as
indicated in the survey results. In the long term, it is predicted that participant use of this toolbox
will improve health outcomes in this patient population if toolbox use is continued. Participants
should note that practice guidelines may be updated in the future and will need to make changes
accordingly if they wish to continue toolbox use.
Time is found to be a barrier for both providers and patients. Providers express difficulty
providing in-depth education on CVD prevention due to short appointment times, and providers
report that patients are often unable or unwilling to take the time for preventative care and follow
up. A potential solution to this dilemma would be to include alternate forms of CVD education in
addition to typical provider-to-patient verbal education. Providers at Sea Mar Monroe may use
EPIC’s patient education materials on CVD and attach it to the after-visit summary. This has the
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potential to increase patient education in a manner that is time-sparing for both patients and
providers. Additionally, providers may take advantage of referring WOC at risk for CVD to the
clinic health educator or dietician for further counseling.
Additionally, this toolbox has the potential to be used in other practice settings where
primary and preventative care is delivered. With the exception of health indicators specific to
Snohomish County and Washington state, the toolbox is generalizable to a national audience.
Local statistics may be updated or removed if it were to be used in a different geographical
location. Additionally, Sea Mar Monroe may wish to distribute this toolbox to their other clinic
locations throughout Washington State.
Conclusion
Disparities in both CVD risk and CVD knowledge and awareness exist among women of
color in the United States. Primary care providers are in a position to ameliorate these disparities
by providing patient education on this topic and partnering with patients on risk reduction
strategies. This practice improvement project demonstrated that a provider toolbox of CVD in
WOC was beneficial in raising both provider and patient knowledge and awareness of this topic
in the primary care setting. In future practice, providers should take care to deliver patient
education that is mindful of both patient and provider time.
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WOMEN OF COLOR AND CVD
THE PROBLEM: Women of Color have an increased risk of
cardiovascular disease (CVD) paired with a decreased knowledge and
understanding of CVD.
§

CVD is the #1 killer of American women. (AHA, 2018)

§

The prevalence of CVD in White women is 35%, compared to 48% in women of
color. (AHA, 2018)

§

African American women have the highest mortality rate from CVD out of any
female racial or ethnic group in the U.S. (CDC, n.d.; Villablanca et al., 2010)

§

Hispanic women are more likely to have risk factors associated with CVD such
as diabetes and obesity (Giardina et al., 2013)

§

South Asian persons have an increased risk of morbidity and mortality from
ischemic heart disease and have not benefitted from the same decline in cases as
the general population over the last few decades (Graham, 2015).

§

Only 36% of Black women and 34% of Hispanic women were able to
identify CVD as women’s number one cause of death, compared to 65% of
White women in a national survey by the American Heart Association. Read
more about the study HERE

§

Decreased knowledge and awareness have been associated with decreased
strategy to take preventative action against CVD (Christian et al., 2007).

§

Physicians are more likely to falsely rate women at lower risk for CVD than men,
underutilizing preventative strategies (Bairey Merz, 2017; Wenger, 2012)

THE PURPORSE of this toolbox is
to 1) Raise provider awareness on
the disparities that exist in CVD risk
and knowledge in women of color
and 2) Equip providers with a
resource to facilitate preventative
strategies with patients who are
women of color.
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CVD: A PRIMER
CVD is an umbrella term that includes numerous manifestations of cardiac and vascular
disease. There are four diagnostic categories of CVD:
1. Coronary Heart Disease (e.g. MI, Angina Pectoris)
2. Cerebrovascular Disease (e.g. Stroke, TIA)
3. Peripheral Arterial Disease
4. Aortic Atherosclerosis or Aneurysm
Healthy People 2020 has two main objectives
related to CVD: 1) To increase the overall
cardiovascular health in the U.S. and 2) To
reduce the number of coronary heart disease
deaths (baseline: 129.2 deaths per 100,000
people; target: 103.4 deaths per 100,000
people).

Risk Factors for CVD can be divided into modifiable and nonmodifiable.
Modifiable risk factors are estimated to be the cause of more than one half of the
mortality associated with CVD. The most common include (Hennekens, 2020):
§ Hypercholesterolemia
§ Diabetes
§ Hypertension
§ Overweight and Obesity
§ Physical Inactivity
§ Unhealthy Diet
§ Smoking or Tobacco Use
§ Metabolic Syndrome
Nonmodifiable Risk Factors
§ Family History of CVD, especially premature CVD—age <55 males/<65 females
§ Age >65 (compared to >55 in males)
§ High Risk Race or Ethnicity
§ Low Socioeconomic Status
§ Poor Access to Healthcare and Preventative Services
§ CKD
§ Chronic Inflammatory Conditions
Risk Factors Unique to Women (ACOG, 2016; Douglas & Poppas, 2019).
§ Early Menarche
§ Use of Combined Oral Contraceptives (COCs)— Although generally safe, they
are associated with an increased risk of heart attack or stroke in women with
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§
§
§

§
§
§

multiple risk factors for or known atherosclerotic cardiovascular disease
(ASCVD).
Polycystic Ovarian Syndrome (PCOS)
Pregnancy Complications, including gestational hypertension or preeclampsia
and gestational diabetes
Postmenopausal State and Early Menopause (age <40)
o Menopause transition is associated with increased risk (Heart, 2010)
o It is notable that hormone replacement therapy (HRT) was not
demonstrated to be cardioprotective in the WHI and HERS trials
HRT—combined hormone therapy presents a small increase in risk of heart
attack and stroke
Autoimmune Disorders—lupus and rheumatoid arthritis are more common in
women and are associated with increased risk of CVD
Lipoproteins—low HDL, rather than high LDL, is more predicative of risk in
women

Risk Factors by Race & Ethnicity
Disease Risk and Risk Factors Amongst Different Ethnic and Racial Groups (Graham, 2015).
Read the full report HERE
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Health Disparities
Men vs. Women
The risk of CVD is often underestimated in women by both patients and providers.
Under-recognition and variable clinical presentation are related to less aggressive
treatment strategies. Women, especially women of color, are also underrepresented in
clinical trials (Heart, 2010). Additionally, physicians are less likely to discuss risk and
provide preventative care to women than men (American College of Cardiology, 2019).
Men and women may experience different anginal symptoms. Therefore, it is crucial to
educate patients on this matter so that they can identify signs and symptoms of a heart
attack and when to take emergency action. While chest pain is the most common anginal
symptom in both men and women, women are more likely to experience other symptoms
including nausea, shortness of breath, back or jaw pain, or lightheadedness.
Women of Color
Overall, people of color have an increased risk of morbidity and mortality due to CVD
and have not benefited to the same extent from the general decline in heart disease
related deaths in the U.S. over the last few decades (Graham, 2015). Women of color
demonstrate a higher mortality rate from CVD than White women. In particular,
African American women have a higher death rate from CVD compared to White
females and mortality is more likely to occur at a younger age (CDC, n.d.; Graham, 2015). Black
and Hispanic women have the highest rates of obesity, hypertension and diabetes in the
U.S., contributing to increased risk.
There also exists a knowledge gap in women of color on awareness of heart disease as
women’s number one health threat (American Heart Association, 2018; Reeder, 2017; Villablanca et al., 2016).
This is significant because decreased knowledge and awareness have been associated
with decreased strategy to take preventative action against CVD (Christian et al., 2007).

HEALTH INDICATORS
National
Heart disease, which is responsible for 22.3% of deaths in women nationally, is the
leading cause of death in women in the United States and coronary artery disease is the
most common form (CDC, 2020). Black women in the United States exhibit the highest rates
of both hospitalization and death from CVD nationwide (CDC, n.d.; CDC, 2020).
National CVD Hospitalization Rate per 1,000 Medicare Beneficiaries, Women Age
65+, 2015-2017
All Races/Ethnicities
53.3
Black
79
White
51.5
Hispanic
49.5
(CDC, n.d.)

6

National CVD Death rate per 100,000, Women, All Ages, 2016-2018
All Races/Ethnicities
179.6
American Indian/Alaskan Native
158.9
Asian and Pacific Islander
108
Non-Hispanic Black
238.6
Hispanic
131.4
Non-Hispanic White
180.8
(CDC, n.d.)

Check out the CDC’s Interactive Atlas of Heart Disease and Stroke to compare CVD
hospitalization and death rates by race/ethnicity, gender and geographical location.

Local
In Washington State, CVD is the second leading cause of death in women after cancer,
compared to the leading cause nationally (Washington State Department of Health, 2017). In Washington
state, Black women have the highest hospitalization rate. However, American Indian and
Alaskan Native women have the highest death rate, followed by Black women and then
White women. Hispanic women have a higher hospitalization rate than White women,
however, their death rate is lower.
Washington State CVD Hospitalization Rate per 1,000 Medicare Beneficiaries,
Women Age 65+, 2015-2017*
All Races/Ethnicities
42.2
Black
64.7
White
42.1
Hispanic
46
(CDC, n.d.)

*National Rate: 53.3
Washington State CVD Death rate per 100,000, Women, All Ages, 2016-2018*
All Races/Ethnicities
152
American Indian/Alaskan Native
195.6
Asian and Pacific Islander
104.1
Non-Hispanic Black
187
Hispanic
111.1
Non-Hispanic White
155.8
(CDC, n.d.)

*National Rate: 179.6
In Snohomish County, CVD is also the second leading cause of death after cancer
(Washington State Department of Health, 2017). Black women are disproportionately affected by CVD.
Hospitalizations in Black women are above both the state and national rate and deaths in
Black women are above the state rate. Additionally, American Indian and Alaskan
Native women demonstrate a death rate that exceeds both the state and national rate (CDC,
n.d.).
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SNOHOMISH COUNTY
RACE AND ETHNICITY
Other 5%

POPULATION

BY

American
Indian and
Alaskan Native
1%
Asian and
Pacific Islander
11%
Non-Hispanic
Black
3%
Hispanic
10%

Non-Hispanic
White
70%

(CDC, n.d.)

Snohomish County CVD Hospitalization rate per 1,000 Medicare beneficiaries,
Women, Age 65+ 2015-2017*
All Races/Ethnicities
42.3
Non-Hispanic Black
60.3
Non-Hispanic White
43.3
Hispanic
Insufficient data
(CDC, n.d.)

*National Rate: 53.3, State Rate: 42.2
Snohomish County CVD Death rate per 100,000, Women, All Ages, 2016-2018*
All Races/Ethnicities
145.1
American Indian/Alaskan Native
188.7
Asian and Pacific Islander
91.9
Non-Hispanic Black
173.7
Hispanic
95.8
Non-Hispanic White
149.6
(CDC, n.d.)

*National Rate: 179.6, State Rate: 152
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CURRENT PRACTICE GUIDELINES
Top 10 Takeaways from the 2019 ACC/AHA Guidelines on the
Primary Prevention of Cardiovascular Disease:
1. The most important way to prevent ASCVD, heart failure and atrial fibrillation is
through promotion of a healthy lifestyle across the lifespan.
2. A team-based care approach is an effective strategy for the prevention of
cardiovascular disease. Clinicians should evaluate the social determinants of
health that affect individuals to inform treatment decisions.
3. Adults who are 40 to 75 years of age and are being evaluated for
cardiovascular disease prevention should undergo 10-year atherosclerotic
cardiovascular disease (ASCVD) risk estimation and have a clinician–patient
risk discussion before starting on pharmacological therapy, such as
antihypertensive therapy, a statin, or aspirin. In addition, assessing for other
risk-enhancing factors can help guide decisions about preventive
interventions in select individuals, as can coronary artery calcium scanning.
4. All adults should consume a healthy diet that emphasizes the intake of
vegetables, fruits, nuts, whole grains, lean vegetable or animal protein, and
fish and minimizes the intake of trans fats, red meat and processed red
meats, refined carbohydrates, and sweetened beverages. For adults with
overweight and obesity, counseling and caloric restriction are recommended
for achieving and maintaining weight loss.
5. Adults should engage in at least 150 minutes per week of accumulated
moderate-intensity physical activity or 75 minutes per week of vigorousintensity physical activity.
6. For adults with type 2 diabetes mellitus, lifestyle changes, such as improving
dietary habits and achieving exercise recommendations, are crucial. If
medication is indicated, metformin is first-line therapy, followed by
consideration of a sodium-glucose cotransporter 2 inhibitor or a glucagonlike peptide-1 receptor agonist.
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7. All adults should be assessed at every healthcare visit for tobacco use, and
those who use tobacco should be assisted and strongly advised to quit
8. Aspirin should be used infrequently in the routine primary prevention of
ASCVD because of lack of net benefit.
9. Statin therapy is first-line treatment for primary prevention of ASCVD in
patients with elevated low- density lipoprotein cholesterol levels (>/=190
mg/dL), those with diabetes mellitus, who are 40 to 75 years of age, and
those determined to be at sufficient ASCVD risk after a clinician–patient risk
discussion
10. Nonpharmacological interventions are recommended for all adults with
elevated blood pressure or hyper- tension. For those requiring
pharmacological therapy, the target blood pressure should generally be
<130/80 mm Hg
Read the full report HERE
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ABCDE of Primary Prevention: Lifestyle Changes and TeamBased Care

The ABCs of Primary Cardiovascular Prevention: 2019 Update.
(Alfaddagh, Arps, Blumenthal & Martin, 2019)

Aspirin
Aspirin is no longer recommended as pharmacologic treatment for the primary
prevention of ASCVD due to lack of net benefit. However, it is still recommended as
secondary prevention. Primary prevention with low-dose aspirin may be considered in
select patients who have high-risk for ASCVD* and are not an increased risk for
bleeding (Rubenfire, 2019).
*See ASCVD risk below

11

Blood Pressure
ACC/AHA 2017 Classification for Hypertension: (Rubenfire, 2019).
Blood Pressure
Systolic
Diastolic
Normal
<120
<80
Elevated
120-129
<80
Stage 1
130-139
80-89
Stage 2
≥140
≥90
ACC/AHA 2017 vs. JNC 8: When to Start Pharmacotherapy
ACC/AHA
JNC 8
Patients w/o CVD and
At 140/90
Patients ages <60 At 140/90
10-year risk <10%
Patients w/ CVD or 10At 130/80
Patients ages 60+ At 150/90
year risk >/=10%
Patients ages 65+
SBP ≥130
Patients w/
At 140/90
diabetes
Patients w/ Diabetes
At 130/80
Patients w/ CKD
At 140/90
Patients w/ CKD
At 130/80
ACC/AHA 2017 vs. JNC 8: Blood Pressure Goals in Patients with Hypertension
ACC/AHA*
JNC 8
Most Patients
<130/80
Patients ages <60
<140/90
Patients ages 65+**
SBP <130
Patients ages
<150/90
60+***
Post stroke or TIA w/o
<130/80
Patients w/ Diabetes <140/90
previously treated HTN
Post stroke or TIA w/
<140/90
Patients w/ CKD
<140/90
previously treated HTN
(Hernandez-Villa, 2015; Ripley & Barbato, 2018)

*Lower goals influenced by the results of the SPRINT Trial.
**Consider risk for falls, dementia or Parkinson’s, orthostasis, other comorbidities and
limited life expectancy.
***No need to back off treatment if SBP of <140 is achieved and treatment is well
tolerated.
Pharmacologic Implications:
According to both the ACC/AHA and JNC 8 guidelines, race should be considered when
initiating pharmacologic therapy, specifically in Black patients.
The ACC/AHA recommends the use of thiazide diuretics or calcium-channel
blockers as first line treatment in the management of hypertension in Black patients,
including those with diabetes. (Carey, Whelton, & 2017 ACC/AHA Hypertension Guideline Writing Committee,
2018).
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The JNC 8 also recommends the use of a thiazide diuretic or a calcium-channel
blocker for the initial treatment of hypertension in the Black population (general Black
population- moderate, grade B recommendation; Black with diabetes- weak, grade C
recommendation). These findings are based on results from the ALLHAT trial which
demonstrated better cardiovascular outcomes in Black patients than when using ACEInhibitors. ACE-Inhibitors were also found to be less effective in lowering blood
pressure as opposed to calcium-channel blockers in the black population. (James et al., 2014).

Cholesterol: ASCVD Risk & Statin Recommendations
ASCVD Risk Calculator
Risk calculators provide a frame of reference for risk in patients without ASCVD using
population-based and clinical trial outcomes with the goal of matching need for and
intensity of preventative therapies to absolute risk of an ASCVD event in the next 10
years (ACC/AHA, 2019). It is recommended that patients ages 20 and older without established
ASCVD should undergo periodic risk assessment every three to five years (Douglas & Poppas,
2019).

Calculate HERE
However, it is essential that providers recognize that risk calculators do not consider all
risk factors contributing to higher risk, such as low socioeconomic status
(SES), race and risk factors unique to women. In fact, the risk calculator is best
validated among non-Hispanic Whites and non-Hispanic Blacks. This may inaccurately
assess risk in patients of other races and ethnicities who are known to be at greater risk,
including Latinx and South Asian ancestry (Rubenfire, 2019).
Additional Considerations from the ACC/AHA 2019 Guidelines on the Primary
Prevention of CVD: (ACC/AHA, 2019)
§ No single risk calculator is effective for all patients
§ Risk may be underestimated in patients with chronic inflammatory conditions
(e.g. autoimmune conditions) or HIV/AIDS and low SES. Patients with familial
hypercholesterolemia are also at increased risk not captured in risk calculators.
§ Risk may be overestimated in patients with higher SES and those with continual
access to care and preventative services.
§ Thus, in patients who score borderline (5% to <7.5%) or intermediate (>/=7.5%
to <20%), additional risk-enhancing clinical factors should be considered:
o Family History of Premature ASCVD
o Primary Hypercholesterolemia
o Metabolic Syndrome
o Chronic Kidney Disease
o Chronic Inflammatory Conditions
o Conditions Specific to Women
§ Early menarche, early menopause, pregnancy complications,
PCOS, HRT
o High Risk Race/Ethnicity
o Lipids & Biomarkers Associated with Increased ASCVD Risk:
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§
§
§
§
§

Persistent hypertriglyceridemia (≥ 175)
Elevated High-Sensitivity C-Reactive Protein (≥2 mg/dL)
Elevated Lp(a) levels (≥50 mg/dL or ≥125 nmol/L)
Elevated ApoB levels ≥ 130 mg/dL
ABI >0.9

Statin Recommendations
From the 2019 ACC/AHA Guideline on the Primary Prevention of CVD: (Rubenfire, 2019)
§
§

§
§

Patients ages 20-75 years and LDL-C ≥190 mg/dl: Use a high-intensity statin
without risk assessment.
Patients ages 40-75 and Type 2 Diabetes: Use a moderate-intensity statin and
risk estimation to consider a high-intensity statin. Risk-enhancers in diabetics
include ≥10 years for T2DM and 20 years for type 1 DM, ≥30 mcg albumin/mg
creatinine, eGFR <60 ml/min/1.73 m2, retinopathy, neuropathy, ABI <0.9. In
those with multiple ASCVD risk factors, consider high-intensity statin with aim
of lowering LDL-C by 50% or more.
Patients ages >75 years: Clinical assessment and risk discussion.
Patients ages 40-75 years and LDL-C ≥70 mg/dl and <190 mg/dl without
diabetes: Use the risk estimator that best fits the patient and risk-enhancing
factors to decide the intensity of statin needed.
o Borderline Risk (5% to <7.5%): Risk discussion-- if risk-enhancing
factors are present, discuss moderate-intensity statin and consider
coronary CACs in select cases.
o Intermediate Risk (≥7.5-20%): Risk discussion-- use moderate-intensity
statins and increase to high-intensity with risk enhancers. Option of CACs
to risk stratify if there is uncertainty about risk. If CAC = 0, can avoid
statins and repeat CAC in the future (5-10 years), the exceptions being
high-risk conditions such as diabetes, family history of premature CHD,
and smoking. If CACs 1-100, it is reasonable to initiate moderateintensity statin for persons ≥55 years. If CAC >100 or 75th percentile or
higher, use statin at any age.
o High Risk (≥20%): Risk discussion to initiate high-intensity statin to
reduce LDL-C by ≥50%.

Tobacco
Both tobacco use (including secondhand smoke) and smokeless tobacco are associated
with increased ASCVD risk. It is estimated that 1/3 of CHD deaths are attributed to
tobacco use. E-cigarettes are a tobacco delivery device that is growing in popularity,
especially amongst youth and young adults. Because they are fairly new products, the
long-term health risks are not certain. However, current research suggests that they
contribute to cardiac and pulmonary disease. Case reports have also shown arrythmias
and hypertension associated with e-cigarette use. All adults should be assessed for
tobacco use at each visit and counseled on cessation if appropriate. Treatments include
behavioral modification, nicotine replacement therapy or drug treatment with varenicline
or bupropion (Rubenfire, 2019).
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The ABCs of Primary Cardiovascular Prevention: 2019 Update.
(Alfaddagh, Arps, Blumenthal & Martin, 2019).

Diabetes
The development and progression of type 2 diabetes mellitus is heavily influenced by
diet, physical activity, and body weight. The ACC/AHA recommends dietary counseling
for a heart-healthy diet that lowers CVD events and CVD mortality, including the
Mediterranean, DASH, and vegetarian/vegan diets in order to aid weight loss and
glycemic control. It is estimated that at least 150 minutes/week of moderate to vigorous
physical activity can lower HbA1c by 0.7%. The recommended first-line therapy in the
treatment of diabetes to reduce CVD risk is metformin with a goal HbA1c of 6.5-7%. In
comparison to lifestyle modifications, metformin has been shown to reduce micro- and
macrovascular diabetes-related complications by 32% and reduce MIs by 39%. Other
popular medications used for glycemic control, including sulfonylureas, do not
demonstrate a reduction in ASCVD risk. However, SGLT-2 inhibitors and GLP-1R
agonists have been shown to reduce ASCVD events and may be an appropriate addition
to metformin for the prevention of ASCVD (Rubenfire, 2019).

Diet, Weight & Exercise
Dietary habits associated with increased risk of CVD mortality include sugar, lowcalorie sweeteners, high-carbohydrate diets, low-carbohydrate diets, refined grains, trans
fat, saturated fat, sodium, red meat, and processed red meat (e.g. bacon, salami, ham,
etc). A plant-based diet or Mediterranean-like diet is associated with a decrease in
ASCVD and all-cause mortality. The ACC/AHA recommendation is for a diet high in
vegetables, fruits, nuts, whole grains, lean vegetable or animal protein (preferably fish),
and vegetable fiber. Diets focused on low carbohydrate intake and high intake of animal
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fat and protein are associated with increased cardiac and non-cardiac mortality (Rubenfire,
2019).

A diagnosis of obesity can be made by a BMI ≥30 kg/m2 and a diagnosis of overweight
by a BMI of 25-29.9 kg/m2. The ACC/AHA recommendation is for a low-calorie diet
(500 calorie reduction) and high levels of physical activity (200-300 minutes/week).
Clinically meaningful weight loss is defined as ≥5% initial weight and is associated with
improvement in blood pressure, LDL-C, triglyceride, and glucose levels among obese or
overweight individuals, and delays the development of type 2 diabetes mellitus (Rubenfire,
2019).

Adequate aerobic exercise is associated with decreased risk of ASCVD. The current
recommendation from the ACC/AHA is for 150 minutes/week of moderate intensity or
75 minutes/week vigorous intensity physical activity (Rubenfire, 2019).

PATIENT EDUCATION
Health care providers
should partner with
patients who are women
of color to empower them
in doing their part to
reduce the risk of
cardiovascular disease.
Here are some important
education points and
resources for reducing the
risk and increasing
knowledge and
awareness in this patient population.
Signs & Symptoms of Heart Attack Unique to Women
Emphasize that women are more likely than men to experience anginal symptoms other
than chest pain. Women are less likely to realize they are having a heart attack and
therefore delay seeking care. Providers should educate women on the warning signs that
they may be having a heart attack, including:
§ Chest Tightness or Pressure
§ Diaphoresis
§ Shortness of Breath
§ Fatigue or Lightheadedness
§ Back, Neck or Jaw Pain
§ Nausea
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Image: https://health.clevelandclinic.org/how-to-protect-yourself-against-heart-and-vascular-disease/
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Women of Color: Increasing Knowledge and Awareness
The current literature reveals that women of color have a decreased knowledge and
awareness of heart disease. Talk with your patients, especially women of color, about
heart disease as women’s number one health threat.
Here is some helpful information for patients on CVD as women’s number one
health threat and how it disproportionately affects women of color in the
United States: Cardiovascular Disease: Women's #1 Health Threat (American Heart
Association, 2018)

In addition to heart attack signs and symptoms unique to women, women of color
should be aware of varying presentation impacted by race and ethnicity. A literature
review by the American Heart Association (Graham et al., 2012) found that patients of racial
and ethnic minorities presenting with CHD were more likely to be younger, be female
and have other comorbidities such as diabetes, hypertension and obesity. Other key
findings highlighted in this review include:
§
In a study of elderly Black women with CHD, patients were more likely to
experience unusual fatigue and sleep disturbance as prodromal symptoms, with
less than half experiencing chest pain or discomfort.
§
The most acute symptom in women of racial or ethnic minorities was found to be
shortness of breath.
§
In Hispanics undergoing coronary artery bypass graft surgery, patients are more
likely to have more comorbidities, be female, be younger and have a lower BMI
than others
§
Chinese, South Asian and Southeast Asian patients were more likely to
experience typical prodromal symptoms (i.e. chest pain or discomfort), however,
were more likely to delay time to seeking emergency care.
Read the review HERE
Modifiable Risk Factors
Educate your patients on everyday things they
can do to actively take part in reducing their
risk of cardiovascular disease.
§
§
§
§
§

Talk about a heart healthy diet
Counsel on weight loss if appropriate
Encourage regular aerobic exercise
Counsel on smoking and tobacco
cessation if appropriate
Brainstorm ways to manage stress
(Image: https://www.everydayhealth.com/hs/type-2-diabetes/heart-disease-risk-factors/)
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Helping Your Patients Monitor Blood Pressure
African Americans have the highest incidence of hypertension in both men and women
in the world. Emphasize that hypertension, often called “this silent killer”, usually does
not have any symptoms until the damage has already been done.
Point out measures that patients can take on a day-to-day basis to help lower blood
pressure
§ Eating a healthy diet, low in sodium—educate patients on reading nutrition labels
and foods high in sodium (e.g. processed and packaged foods)
§ Engaging in regular physical activity
§ Maintaining a healthy weight
§ Manage stress
§ Limit alcohol intake
§ Discuss medications, both OTC and prescription, used—many OTC medications,
including commonly used decongestants and NSAIDs, can elevate blood pressure
Patient blood pressure logs provided by the Washington State Department of Health—
print and review with your patient at their next visit. (Washington State Department of Health, n.d.)
English
Spanish
How to check your blood pressure manually from the Washington State Department
of Health (Washington State Department of Health, n.d.)
English
Spanish
HERE is a link to the main page with more languages and additional resources for
patients on monitoring their own blood pressure at home

CULTURAL CONSIDERATIONS
Culture & CVD Risk
Cultural beliefs and values influence patient’s understanding of health and illness. In
fact, culture has been shown to have a greater impact on CVD risk and outcomes than
genetics do (Graham et al., 2012). When partnering with patients to reduce risk, it is essential to
assess how culture influences patient’s perceptions of CVD in order to promote
meaningful change. However, limited studies exist on culture as it relates to women of
color’s perceptions of heart health.
§
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State of the Science—Selected Literature
A systematic review found that cultural beliefs surrounding health and illness
contribute to the patient’s ability to understand and act on information and

instructions given by healthcare providers, indicating a need for provider
assessment of cultural and language barriers and healthy literacy. (Shaw et al., 2008)
§

A systematic review exploring how culture influences understanding of advanced
heart failure found that symptoms were strongly related to cultural beliefs.
Patients from Eastern and Middle Eastern cultures were found to somaticize
symptoms more than patients of Western cultures. However, patients of Western
cultures reported higher symptoms distress. Cultural beliefs impacted knowledge
of heart failure diagnosis, cause, treatment, self-management and decisions about
care and health behaviors. (Alassoud et al., 2020)

§

A qualitative study revealed that African Americans were less likely to associate
overweight and obesity and risk factors for CVD than other traditional risk
factors (e.g. physical inactivity, poor diet, etc.). Participants of this study reported
that they were open to modifying health behaviors if changes incorporated their
input and were culturally acceptable. (Der Ananian et al., 2018)

§

A mixed-methods study found that women of color, including Black, Latina and
Asian American women, based their perceptions of CVD on past familial and
cultural experiences, personal loss, personal sense of empowerment and
complicated relationships with physicians. (Tindall & Vardeman-Winter, 2011)

Assessing Your Patient’s Perception of Risk as it Relates to Culture

(Image: https://www.meadowsranch.com/how-body-diversity-can-help-women-build-a-positive-body-image/)

Assess cultural perceptions about body image—does the patient view themselves as
overweight/obese or culturally normal? What does you patient and their culture view as
overweight? (American Heart Association, 2019).
Assess cultural beliefs about exercise—how useful is exercise for preventing disease?
Are there cultural restrictions on the type and setting in which exercise may occur? (Chyun
et al., 2003)

Assess cultural beliefs about diet—what is this culture’s eating habits and dietary
practices? What does the patient think is a healthy diet? What foods are important to
their culture? (Chyun et al., 2003)
Assess beliefs about smoking-- Is smoking or tobacco use a cultural norm? Are there
cultural barriers to cessation? (Chyun et al., 2003)
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Assess cultural perceptions of stress—how does the patient and their culture perceive
stress? What are stressors for this
population? Does racism or discrimination
contribute to stress for this patient or her
culture? (Shaw et al., 2008)
(Image: https://www.nursingcenter.com/ncblog/november2019/social-determinants-of-health)

Social Determinants of Health &
Barriers
Socioeconomic inequalities are
known determinants of
cardiovascular health. It is
recommended that providers consider social determinants of health when
counseling patients on risk factor reduction strategies (American Heart Association, 2019).
The main categories of social determinants of health, often intertwined, include: (Havranek et
al., 2015)

§
§
§
§
§
§

Socioeconomic Position
Race and Ethnicity
Social Support
Culture and Language
Access to Care
Residential Environment

Consider:
Access— healthy foods, health care, financial resources, transportation to appointments
Neighborhood Safety—may impact likelihood of engaging in physical activity
Education and Language Barriers— this can heavily impact health literacy, the
ability to understand or act on medical or therapeutic instructions.
Cultural Norms—how does culture impact perception of risk?
Family Support—does this patient have an adequate support system in place to achieve
health related goals?

In sum, women of color are at an increased risk for CVD and decreased
knowledge and awareness are doing them a disservice. I hope that you will
use this toolbox as a resource and take special care to inform this patient
population on heart disease and partner with them to reduce risk.
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Appendix B: Participant Executive Summary

A Provider Toolbox on Cardiovascular Disease Prevention in
Women of Color in the Primary Care Setting:
Executive Summary

Ellerey Nelson, RN, BSN
Seattle University

Background
Cardiovascular disease is the leading cause of death in women in the United States.
Women of color (WOC) have a higher risk of CVD, paired with a decreased knowledge and
understanding of CVD, compared to White women. In addition, healthcare providers are known
to underestimate risk in this population, indicating a need for increased awareness amongst
providers. Thus, the primary investigator of this scholarly project identified a need to close this
gap in heart health knowledge between WOC and White women through enhanced provider to
patient education in order to reduce further health disparity. A provider toolbox for CVD
prevention in WOC in the primary care setting was therefore assembled and distributed to
participants for clinic use.
Participant Survey Results
The participant survey had a 50% response rate (n=4). Overall, participants rated the
toolbox favorably. The quantitative data from the Likert-type items and fill in the blank item is
described below with accompanying bar graphs indicating the frequency of responses and the
median and mode. The qualitative data from the free response questions, which underwent
content analysis for themes, is summarized below.
Quantitative Data
Sea Mar Monroe clinic sees a mean of 15.3 patients who are WOC for CVD weekly
(Question 1), according to participants who responded to this question (n=3). All participants
(n=4) strongly agreed that the toolbox informed their knowledge on WOC and CVD (see Figure
1). 50% of participants strongly agreed that they felt better equipped to address this clinical
practice issue after viewing the toolbox and its presentation, and the other 50% of participants
somewhat agreed (see Figure 2). All participants strongly agreed that the toolbox will enable
them to optimize cardiovascular care of WOC at risk for CVD (see Figure 3). All participants
strongly agreed that the toolbox resource will help them facilitate evidence-based practice in
their practice setting (see Figure 4).
The median and mode were analyzed to determine central tendency of responses. The
scale for the responses ranged from numbers 1 through 5, with 1= strongly disagree and 5=
strongly agree. Based on this information, it can be determined that the central tendency of
responses was consistent with “strongly agree” for all questions except question three, which
ranged from “agree” to “strongly agree” (see Table 1).

Qualitative Data
The common themes identified were conceptualizing race as a specific risk factor, time as
a barrier for both providers and WOC, and money and lack of prioritization as barriers for WOC.
Race as a Specific Risk Factor. Participants indicated that the toolbox helped reinforce
their knowledge of race as a specific risk factor for CVD. One respondent indicated that
providers often approach patients in an algorithmic fashion when considering risk factors, and
race is often overlooked.
Time & Money. Time was an overarching theme related to barriers for CVD prevention
for both providers and WOC. Participants wrote that short appointment times inhibited them
from being able to provide adequate CVD education to patients. Additionally, lack of time was
identified as a barrier for WOC to seek preventative care or make follow up appointments.
Lack of Prioritization. Another theme was family prioritization. Participants described
WOC patients as mothers, spouses and full-time workers, making them more likely to put their
own health “on the back burner” and prioritize family needs above their own.
Implications for Future Practice
The information and resources in the toolbox served as a useful resource in both
increasing provider awareness of this health disparity and educating WOC patients on CVD. In
the long term, it is predicted that use of this toolbox will improve health outcomes in this patient
population if toolbox use is continued. Participants should note that practice guidelines will need
to be periodically reviewed and changes made to the toolbox as indicated.
Time was found to be a barrier for both providers and patients. Providers expressed
difficulty providing in-depth education on CVD prevention due to short appointment times, and
providers reported that patients are often unable or unwilling to take the time for preventative
care and follow up. A potential solution to this dilemma would be to include alternate forms of
CVD education in addition to typical provider-to-patient verbal education. Providers may use
EPIC’s patient education materials on CVD and attach it to the after-visit summary. This has the
potential to increase patient education in a manner that is time-sparing for both patients and
providers. Additionally, providers may take advantage of referring WOC at risk for CVD to the
clinic health educator or nutritionist for further counseling.
Additionally, this toolbox has the potential to be used in other practice settings where
primary and preventative care is delivered. With the exception of health indicators specific to

Snohomish County, the toolbox is generalizable to a national audience, and Sea Mar Monroe
may wish to distribute this toolbox to their other clinic locations throughout Washington State.
Figure 1
Question 2

Note. “This toolbox has informed my knowledge on this clinical practice issue.”
Figure 2
Question 3

Note. “I feel better equipped to address this clinical practice issue after viewing this toolbox and
presentation.”
Figure 3
Question 4

Note. “The toolbox will enable me to optimize the cardiovascular care of women of color at risk
for CVD.”
Figure 4
Question 5

Note. “I anticipate that the toolbox resources will help me to facilitate evidence-based practice in
my practice setting.”
Table 1
Median and Mode of Likert-type Item Responses
Variable

Median

Mode

Question 2

5

5

Question 3

4.5

4, 5

Question 4

5

5

Question 5

5

5

Appendix C: Participant Survey
Approximately how many patients who are women of color do you see (have an appointment
with) on a weekly basis?
This toolbox has informed my knowledge on CVD and women of color.
__Strongly Agree
__Agree
__Neutral
__Disagree
__Strongly Disagree
I feel better equipped to address this clinical practice issue after viewing this toolbox and
presentation.
__Strongly Agree
__Agree
__Neutral
__Disagree
__Strongly Disagree
The toolbox will enable me to optimize the cardiovascular care of women of color at risk for
CVD.
__Strongly Agree
__Agree
__Neutral
__Disagree
__Strongly Disagree
I anticipate that the toolbox resources will help me to facilitate evidence-based practice in my
practice setting.
__Strongly Agree
__Agree
__Neutral
__Disagree
__Strongly Disagree
How has this toolbox impacted your approach to care of patients who are women of color at risk
for CVD? Please explain.
How do you expect that provider use of this toolbox will impact patient outcomes? Please
explain.

What barriers do you believe providers face in providing CVD education to patients? Please
explain.
What barriers do you believe patients who are women of color face in taking action to reduce
their risk of CVD? Please explain.

